Regulation of dopamine uptake by basic fibroblast growth factor and epidermal growth factor in cultured rat astrocytes

Neuroscience Research

Volumn 34, Issue 4, 1999, Pages 235-244

  Inazu, Masato ^a   Takeda, Hiroshi ^a   Ikoshi, Hideaki ^a   Uchida, Yoshihiro ^a   Kubota, Nobuo ^b   Kiuchi, Yuji ^b   Oguchi, Katsuji ^b   Matsumiya, Teruhiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Astrocytes; Basic fibroblast growth factor; Dopamine; Epidermal growth factor; Extraneuronal monoamine transporter; Organic cation transporter; Uptake2

Indexed keywords

ADENOSINE TRIPHOSPHATASE INHIBITOR; BREFELDIN A; CATECHOL METHYLTRANSFERASE INHIBITOR; CYCLOHEXIMIDE; DACTINOMYCIN; DOPAMINE; DOPAMINE TRANSPORTER; MONOAMINE OXIDASE INHIBITOR; OUABAIN; PARGYLINE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; SODIUM ION; TRITIUM; TROPOLONE;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE UPTAKE; DOSE TIME EFFECT RELATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; TEMPERATURE;

ANIMALS; ASTROCYTES; BREFELDIN A; CELLS, CULTURED; CYCLOHEXIMIDE; DACTINOMYCIN; DOPAMINE; DOPAMINE ANTAGONISTS; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; NA(+)-K(+)-EXCHANGING ATPASE; NUCLEIC ACID SYNTHESIS INHIBITORS; OUABAIN; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM; TIME FACTORS;

EID: 0032844007     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(99)00053-X     Document Type: Article

References (68)

1. Altar C.A., Marien M.R., Marshall J.F. Time course of adaptations in dopamine biosynthesis, metabolism, and release following nigrostriatal lesions: implications for behavioral recovery from brain injury. J. Neurochem. 48:1987;390-399.
2. Andersen P.H. The dopamine uptake inhibitor GBR-12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 166:1989;493-504.
3. Amara S.G., Kuhar M.J. Neurotransmitter transporter: recent progress. Annu. Rev. Neurosci. 16:1993;73-93.
4. Bakhit C., Armanini M., Bennett G.L., Wong W.L.T., Hansen S.E., Taylor R. Increase in glia-derived nerve growth factor following destruction of hippocampal neurons. Brain Res. 560:1991;76-83.
5. Bean A., Elde R., Cao Y., Oellig C., Tamminga C., Goldstein M. et al. Expression of acidic and basic fibroblast growth factors in the substantia nigra of rat, monkey, and human. Proc. Natl. Acad. Sci. USA. 88:1991;10237-10241.
6. Bönisch H. Extraneuronal transport of catecholamines. Pharmacol. 21:1980;93-108.
7. Bönisch H., Brüss M. The noradrenaline transporter of the neuronal plasma membrane. Ann. New York Aca. Sci. 733:1994;193-202.
8. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of peotein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
9. Burgess W., Macaig T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58:1989;575-606.
10. Cancilla P.A., Bready J., Berliner J., Sharifi-Nia H., Toga A.W., Santori E.M. et al. Expression of mRNA for glial fibrillary acidic protein after experimental cerebral injury. J. Neuropathol. Exp. Neurol. 51:1992;560-565.
11. Carpenter G., Cohen S. Epidermal growth factor. Annu. Rev. Biochem. 48:1979;193-216.
12. Casper D., Mytilineou C., Blum M. EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture. J. Neurosci. Res. 30:1991;372-381.
13. Eclancher F., Kehrli P., Labourdette G., Sensenbrenner M. Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain. Brain Res. 737:1996;201-214.
14. Eclancher F., Perraud F., Faltin J., Labourdette G., Sensenbrenner M. Reactive astrogliosis after basic fibroblast growth factor (bFGF) injection in injured neonatal rat brain. Glia. 3:1990;502-509.
15. Engele J., Bohn M.C. The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia. J. Neurosci. 11:1991;3070-3078.
16. Fallon J., Seroogy K., Loughlin S., Morrison R., Bradshaw R., Knauer D. et al. Epidermal growth factor immunoreactive material in the central nervous system: location and development. Science. 224:1984;1107-1109.
17. Fallon J., Annis C., Gentry L., Twardzik D., Loughlin S. Localization of cells containing transforming growth factor-α precursor immunoreactivity in the basal ganglia of the adult rat brain. Growth Factors. 2:1990;241-250.
18. Fisher D., Lakshmanan J. Metabolism and effects of epidermal growth factor and related growth factors in mammals. Endocr. Rev. 11:1990;418-422.
19. Frautschy S.A., Walicke P.A., Baird A. Localization of basic fibroblast growth factor and its mRNA after CNS injury. Brain Res. 553:1991;291-299.
20. Giulian D., Baker T.J., Shin L-C.N., Lachman L.B. Interleukin 1 of the central nervous system is produced by ameboid microglia. J. Exp. Med. 164:1986;594-604.
21. Giros B., el Mestikawy S., Bertrand L., Caron M.G. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett. 295:1991;149-154.
22. Giros B., el Mestikawy S., Godinot N., Zheng K., Han H., Yang-Feng T. et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol. Pharmacol. 42:1992;383-390.
23. Gorboulev V., Ulzheimer J.C., Akhoundova A., Ulzheimer-Teuber I., Karbach U., Quester S. et al. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biol. 16:1997;871-881.
24. Gospodarowicz D., Ferrara N., Schweigerer L., Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr. Rev. 8:1987;95-114.
25. Gospodarowicz D. Fibroblast and epidermal growth factors: their uses in vivo and in vitro in studies on cell functions and cell transplantation. Mol. Cell Biochem. 25:1979;79-110.
26. Gründemann D., Gorboulev V., Gambaryan S., Veyhl M., Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature. 372:1994;549-552.
27. Gründemann D., Babin-Ebell J., Martel F., Ording N., Schmidt A., Schömig E. Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. J. Biol. Chem. 272:1997;10408-10413.
28. Gründemann D., Schechinger B., Rappold G.A., Schömig E. Molecular identification of the corticosterone-sensitive extraneuronal catechilamine transporter. Nature Neurosci. 1:1998;349-351.
29. Hansson E., Isacsson H., Sellström A. Characteristics of dopamine and GABA transport in primary cultures of astroglial cells. Acta Physiol. Scand. 121:1984;333-341.
30. Hansson E. Transport of monoamine and amino acid neurotransmitters by primary astroglial cultures. Neurochem. Res. 10:1985;667-675.
31. Hatten M.E., Liem R.K.H., Shelanski M.L., Mason C.A. Astroglia in CNS injury. Glia. 4:1991;233-243.
32. Hösli E., Hösli L. Autoradiographic studies on the uptake of 3H-dopamine by neurons and astrocytes in explant and primary cultures of rat CNS: effects of uptake inhibitors. Int. J. Devl. Neuroscience. 15:1997;45-53.
33. Hozumi I., Chiu F-C., Norton W.T. Biochemical and immunocytochemical changes in glial fibrillary acidic protein after stab wounds. Brain Res. 524:1990;64-71.
34. Ikumi T., Yabuuchi H., Nezu J., Sai Y., Oku A., Shimane M. et al. Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett. 419:1997;107-111.
35. Inazu M., Kubota N., Takeda H., Zhang J., Kiuchi Y., Oguchi K. et al. Pharmacological characterization of dopamine transport in cultured rat astrocytes. Life Sci. 64:1999;2239-2245.
36. Jaye M., Schlessinger J., Dionne C.A. Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim. Biophys. Acta. 1135:1992;185-199.
37. Kaser M.R., Lakshmanan J., Fisher D.A. Comparison between epidermal growth factor, transforming growth factor-α and EGF receptor levels in regions of adult rat brain. Mol. Brain Res. 16:1992;316-322.
38. Kekuda R., Prasad P.D., Wu X., Wang H., Fei Y.J., Leibach F.H. et al. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J. Biol. Chem. 273:1998;15971-15979.
39. Kilty J.E., Lorang D., Amara S.G. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science. 254:1991;578-579.
40. Kumar S., Weingarten D.P., Callahan J.W., Sachar K., de Vellis J. Regulation of mRNAs for three enzymes in the glial cell model C6 cell line. J. Neurochem. 43:1984;1455-1463.
41. Leutz A., Schachner M. Epidermal growth factor stimulates DNA-synthesis of astrocytes in primary cerebellar cultures. Cell Tissue Res. 220:1981;393-404.
42. Logan A., Frautschy S.A., Gonzalez A.-M., Sporn M.B., Baird A. Enhanced expression of transforming growth factor β1 in the rat brain after a localized cerebral injury. Brain Res. 587:1992;216-225.
43. Marquardt H., Hunkapiler M., Hood L., Twardzik D., De Larco J., Stephenson J. et al. Transforming frowth factors produced by retrovirus-transformed rodent fibloblasts and human melanoma cells: amino acid sequence homology with epidermal growth factor. Proc. Natl. Acad. Sci. USA. 80:1983;4684-4688.
44. Massague J. Epidermal growth factor-like transforming growth factor: interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. J. Biol. Chem. 258:1983;13614-13620.
45. Misumi Y., Misumi Y., Miki K., Takatsuki A., Tamura G., Ikehara Y. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. J. Biol. Chem. 261:1986;11398-11403.
46. Morrison R.S., De Vellis J., Lee Y.L., Bradshaw R.A., Eng L.F. Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes. J. Neurosci. Res. 14:1985;167-172.
47. Nakachi N., Kiuchi Y., Inagaki M., Inazu M., Yamazaki Y., Oguchi K. Effects of various dopamine uptake inhibotors on striatal extracellular dopamine levels and behaviours in rats. Eur. J. Pharmacol. 281:1995;195-203.
48. Nieto-Sampedro M., Gomez-Pinilla F., Knauer D.J., Broderick J.T. Epidermal growth factor receptor immunoreactivity in rat brain astrocytes: response to injury. Neurosci. Lett. 91:1988;276-282.
49. Okuda M., Saito H., Urakami Y., Takano M., Inui K. CDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224:1996;500-507.
50. Park T.H., Mytilineou C. Protection from 1-methyl-4-phenylpyridium (MPP+) toxicity and stimulation of regrowth of MPP+-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF. Brain Res. 599:1992;83-97.
51. Pelton E.W., Kimelberg H.K., Shipherd S.V., Bourke R.S. Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture. Life Sci. 28:1981;1655-1663.
52. Pettmann B., Weibel M., Sensenbrenner M., Labourdette G. Purification of two astroglial growth factors from bovine brain. FEBS Lett. 189:1985;1022-1028.
53. Reilly J.F., Kumari V.G. Alterations in fibroblast growth factor receptor expression following brain injury. Exp. Neurol. 140:1996;139-150.
54. Russ H., Staudt K., Martel F., Gliese M., Scömig E. The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia. Eur. J. Neurosci. 8:1996;1256-1264.
55. Shimada S., Kitayama S., Lin C.L., Patel A., Nathakumar E., Gregor P. et al. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science. 254:1991;576-578.
56. Silverstein F., Johnston M.V. Effects of hypoxia-ischemia on monoamine metabolism in the immature brain. Ann. Neurol. 15:1984;342-347.
57. Simpson D., Morrison R., De Vellis J., Herschman H. Epidermal growth factor binding and mitogenic activity on purified populations of cells from the central nervous system. J. Neurosci. Res. 8:1982;453-462.
58. Streich S., Bruss M., Bonisch H. Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 353:1996;328-333.
59. Takami K., Kiyota Y., Iwane M., Miyamoto M., Tsukuda R., Igarashi K. et al. Upregulation of fibroblast growth factor-receptor messenger RNA expression in rat brain following transient forebrain ischemia. Exp. Brain Res. 97:1993;185-194.
60. Terashita S., Dresser M.J., Zhang L., Gray A.T., Yost S.C., Giacomini K.M. Molecular cloning and functional expression of a rabbit renal organic cation transporter. Biochim. Biophys. Acta. 1369:1998;1-6.
61. Thomas K.A. Fibroblast growth factors. FASEB J. 1:1987;434-440.
62. Trendelenburg U. The extraneuronal uptake and metabolism of catecholammines. Trendelenburg U, Weiner N Handbook of Experimental Pharmacology dxc Vol 90/I. 1988;279-319 Springer, Berlin Heidelberg New York.
63. Uhl G.R., Hartig P.R. Transporter explosion: update on uptake. Trends. Pharmacol. Sci. 13:1992;421-425.
64. Ullrich K.J., Rumrich G., Neiteler K., Fritzsch G. Contraluminal transport of organic cations in the proximal tubule of the rat kideny: II: specificity: anilines, phenylalkylamines (catecholamines), heterocyclic compounds (pyridines, quinolines, acridines). Pflügers Arch. 420:1992;29-38.
65. Usdin T.B., Mezey E., Chen C., Brownstein M.J., Hoffman B.J. Cloning of the cocaine-sensitive bovine dopamine transporter. Proc. Natl. Acad. Sci. USA. 88:1991;11168-11171.
66. Vandenbergh D.J., Persico A.M., Uhl G.R. A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res. Mol. Brain Res. 15:1992;161-166.
67. Wu X., Kekuda R., Huang W., Fei Y.J., Leibach F.H., Chen J. et al. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273:1998;32776-32786.
68. Zhang L., Dresser M.J., Chun J.K., Babbitt P.C., Giacomini K.M. Cloning and functional expression of a human liver organic cation transporter. Mol. Pharmacol. 51:1997;913-921.